US2018148689A1PendingUtilityA1
Generation of Inner Ear Cells
Assignee: MASSACHUSETTS EYE & EAR INFIRMARYPriority: Nov 15, 2006Filed: Jan 22, 2018Published: May 31, 2018
Est. expiryNov 15, 2026(~0.3 yrs left)· nominal 20-yr term from priority
Inventors:Albert Edge
C12N 2506/1353C12N 2501/42A61P 27/16C12N 5/062C12N 5/0627
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for generating cells of the inner ear, e.g., hair cells and supporting cells, from stem cells, e.g., mesenchymal stem cells, are provided, as well as compositions including the inner ear cells. Methods for the therapeutic use of the inner ear cells for the treatment of hearing loss are also described.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of generating a differentiated inner ear cell, the method comprising:
contacting a progenitor cell that expresses one or more of nestin, sox2, musashih, or Pax2, with a gamma secretase inhibitor in an amount and for a time sufficient to induce the progenitor cell to express one or more of atonal homolog 1 (Atoh1), jagged 2, p27 Kip , myosin VIIa, or espin, thereby producing a differentiated inner ear cell.
2 . The method of claim 1 , wherein the progenitor cell is obtained by a method comprising:
providing a mesenchymal_stem cell; and culturing the mesenchymal stem cell under conditions sufficient to induce the stem cell to differentiate into the progenitor cell.
3 . The method of claim 2 , wherein the mesenchymal stem cell is obtained from a subject who has sensorineural hair cell loss.
4 . The method of claim 2 , wherein culturing the mesenchymal stem cell comprises maintaining the stem cell in medium comprising an epidermal growth factor, a fibroblast growth factor, or an insulin-like growth factor.
5 . The method of claim 2 , wherein culturing the mesenchymal stem cell comprises maintaining the stem cell in medium comprising neurotrophin-3 or a brain derived neurotrophic factor.
6 . The method of claim 1 , wherein the gamma secretase inhibitor is an aryl sulfonamide, a dibenzazepine, a benzodiazepine, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT), L-685,458, or MK0752.
7 . The method of claim 1 , wherein the differentiated cell is an inner ear auditory hair cell.
8 . The method of claim 7 , wherein the inner ear auditory hair cell expresses Atoh1, myosin7a, epsin and p 27 Kip.
9 . The method of claim 1 , wherein the progenitor cell expresses Sox2 and Pax2.
10 . The method of claim 2 , wherein the progenitor cell expresses Sox2 and Pax2.Join the waitlist — get patent alerts
Track US2018148689A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.